Latest News & Research

Vaping reforms

From 1 July 2024 the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 has changed the way vapes can be sourced, supplied and advertised.

From 1 October 2024 pharmacists will be able to supply vapes with a nicotine concentration of 20 mg/mL or less, to people 18 years or over without a prescription subject to certain conditions and state and territory law.

Cytisine for cessation

A final decision has been made on proposed amendments to the Poisons Schedule in relation to cytisine. The delegate of the Secretary of the Department of Health and Aged Care (the Delegate) made the decision to create new entries for cytisine in Schedules 3 and 4 and Appendix H. Currently there are no cytisine products on the Australian Register of Therapeutic Goods.

RACGP Guidelines - Supporting smoking & vaping cessation: A guide for health professionals

Guidance on smoking and vaping cessation support related to changes to Australia's vaping regulations, as of 1 October 2024.

Pharmaceutical Society of Australia – Professional practice guidelines: nicotine dependence support

The PSA has released new practice guidelines which provide advice to pharmacists when providing smoking cessation support.

Updated Clinical Resources in Pregnancy and Breastfeeding

Smoking is the most common preventable risk factor for pregnancy complications.

E-cigarette use and respiratory symptoms

A prospective study examined e-cigarette use and respiratory symptoms in adolescents and young adults.

Starting a conversation with your patients

Ask, Advise, Help is a quick way for health professionals to form the basic structure for brief advice on smoking cessation care.